These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12183286)

  • 21. [Mutations of gyrA in ciprofloxacin resistant Escherichia coli strains].
    Eraç B; Gill A; Amyes SG; Gülay Z
    Mikrobiyol Bul; 2003; 37(2-3):125-30. PubMed ID: 14593893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in topoisomerase genes of fluoroquinolone-resistant salmonellae in Hong Kong.
    Ling JM; Chan EW; Lam AW; Cheng AF
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3567-73. PubMed ID: 14576119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations in the gyrA gene in Salmonella enterica clinical isolates with decreased ciprofloxacin susceptibility.
    Escribano I; Rodríguez JC; Royo G
    Int J Antimicrob Agents; 2004 Sep; 24(3):300-3. PubMed ID: 15325438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of gyrA mutations, cyclohexane resistance, and the presence of class I integrons in Salmonella enterica from farm animals in England and Wales.
    Liebana E; Clouting C; Cassar CA; Randall LP; Walker RA; Threlfall EJ; Clifton-Hadley FA; Ridley AM; Davies RH
    J Clin Microbiol; 2002 Apr; 40(4):1481-6. PubMed ID: 11923377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of virulence genes and role of gyrA mutations in quinolone resistant and susceptible strains of Salmonella Weltevreden and Newport isolated from seafood.
    Deekshit VK; Kumar BK; Rai P; Karunasagar I; Karunasagar I
    J Appl Microbiol; 2015 Oct; 119(4):970-80. PubMed ID: 26249136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluroquinolone resistance in typhoidal Salmonella and its detection by nalidixic acid disc diffusion.
    Anjum P; Qureshi AH; Rafi S
    J Pak Med Assoc; 2004 Jun; 54(6):295-301. PubMed ID: 15366793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular level understanding of resistance to nalidixic acid in Salmonella enteric serovar typhimurium associates with the S83F sequence type.
    Preethi B; Ramanathan K
    Eur Biophys J; 2016 Jan; 45(1):35-44. PubMed ID: 26329667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nalidixic acid-resistant strains of Salmonella showing decreased susceptibility to fluoroquinolones in the mid-west region of the Republic of Ireland.
    Gorman R; Adley CC
    J Antimicrob Chemother; 2003 Apr; 51(4):1047-9. PubMed ID: 12654768
    [No Abstract]   [Full Text] [Related]  

  • 29. Detection of novel gyrA mutations in nalidixic acid-resistant isolates of Salmonella enterica from patients with diarrhoea.
    Hamidian M; Tajbakhsh M; Tohidpour A; Rahbar M; Zali MR; Walther-Rasmussen J
    Int J Antimicrob Agents; 2011 Apr; 37(4):360-4. PubMed ID: 21371866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of nalidixic acid and ciprofloxacin with wild type and mutated quinolone-resistance-determining region of DNA gyrase A.
    Vashist J; Vishvanath ; Kapoor R; Kapil A; Yennamalli R; Subbarao N; Rajeswari MR
    Indian J Biochem Biophys; 2009 Apr; 46(2):147-53. PubMed ID: 19517991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of gyrA mutations in quinolone-resistant Salmonella enterica by denaturing high-performance liquid chromatography.
    Eaves DJ; Liebana E; Woodward MJ; Piddock LJ
    J Clin Microbiol; 2002 Nov; 40(11):4121-5. PubMed ID: 12409384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of gemifloxacin against clinical isolates of Neisseria gonorrhoeae with and without mutations in the gyrA gene.
    Ruiz J; Marco F; Sierra JM; Aguilar L; Garcia-Mendez E; Mensa J; Jiménez De Anta MT; Vila J
    Int J Antimicrob Agents; 2003 Jul; 22(1):73-6. PubMed ID: 12842332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of mutations in the gyrA gene and class I integron from quinolone-resistant Salmonella enterica serovar Choleraesuis isolates in Taiwan.
    Huang TM; Chang YF; Chang CF
    Vet Microbiol; 2004 Jun; 100(3-4):247-54. PubMed ID: 15145503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes in Salmonella isolated from 12 tertiary-care hospitals in Korea.
    Jeong HS; Kim JA; Shin JH; Chang CL; Jeong J; Cho JH; Kim MN; Kim S; Kim YR; Lee CH; Lee K; Lee MA; Lee WG; Shin JH; Lee JN
    Microb Drug Resist; 2011 Dec; 17(4):551-7. PubMed ID: 21830947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia.
    Hakanen A; Kotilainen P; Huovinen P; Helenius H; Siitonen A
    Emerg Infect Dis; 2001; 7(6):996-1003. PubMed ID: 11747728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High prevalence of nalidixic acid resistant, ciprofloxacin susceptible phenotype among clinical isolates of Escherichia coli and other Enterobacteriaceae.
    Ruiz J; Gómez J; Navia MM; Ribera A; Sierra JM; Marco F; Mensa J; Vila J
    Diagn Microbiol Infect Dis; 2002 Apr; 42(4):257-61. PubMed ID: 12007443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial resistance in clinical isolates of Salmonella enterica serotype Enteritidis: relationships between mutations conferring quinolone resistance, integrons, plasmids and genetic types.
    Soto SM; González-Hevia MA; Mendoza MC
    J Antimicrob Chemother; 2003 May; 51(5):1287-91. PubMed ID: 12668577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of Salmonella spp. mutants with reduced fluoroquinolone susceptibility: importance of efflux pump mechanisms.
    Cebrián L; Rodríguez JC; Escribano I; Royo G
    Chemotherapy; 2005 Mar; 51(1):40-3. PubMed ID: 15767744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quinolone resistance-determining regions of gyrA and parC in Pasteurella multocida strains with different levels of nalidixic acid resistance.
    Cárdenas M; Barbé J; Llagostera M; Miró E; Navarro F; Mirelis B; Prats G; Badiola I
    Antimicrob Agents Chemother; 2001 Mar; 45(3):990-1. PubMed ID: 11270370
    [No Abstract]   [Full Text] [Related]  

  • 40. Investigation of Nalidixic Acid Resistance Mechanism in Salmonella enterica Using Molecular Simulation Techniques.
    Preethi B; Shanthi V; Ramanathan K
    Appl Biochem Biotechnol; 2015 Sep; 177(2):528-40. PubMed ID: 26208690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.